<DOC>
	<DOCNO>NCT03048825</DOCNO>
	<brief_summary>The CLEAR SYNERGY trial study long term effect treatment follow PCI treat ST elevation myocardial infarction . These treatment address culprit artery ( PCI SYNERGY Stent ) well non-culprit artery ( randomization routine colchicine spironolactone ) .</brief_summary>
	<brief_title>Colchicine Spironolactone Patients With STEMI / SYNERGY Stent Registry</brief_title>
	<detailed_description>This multicenter , international SYNERGY Stent registry embed within randomize , blind , double-dummy , 2x2 factorial design trial colchicine versus placebo spironolactone versus placebo patient ST-elevation myocardial infarction undergone primary percutaneous coronary intervention ( PCI ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>1 . Patients STEMI refer PCI within 12 hour symptom onset , culprit lesion amenable stenting ( initial 800 patient receive SYNERGY stent [ SYNERGY Stent phase ] , patient eligible refer within 24 hour symptom onset ) ( All patient participate drug portion require randomize within 24 hour index PCI initial hospitalization ) 2 . Written inform consent 1 . Known allergy contraindication everolimus , SYNERGY stent component 2 . Unable receive dual antiplatelet therapy 3 . Age â‰¤18 year 4 . Pregnancy , breastfeeding , woman childbearing potential use effective method contraception 5 . Any contraindication know intolerance colchicine spironolactone 6 . Requirement colchicine spironolactone another indication 7 . Creatinine clearance &lt; 30 mL/min/1.73 m^2 8 . History cirrhosis current severe hepatic disease 9 . Systolic blood pressure &lt; 90 mm Hg 10 . Serum Potassium &gt; 5.0 meq/L 11 . Current plan use HIV protease inhibitor , azole antifungal , macrolide antibiotic 12 . Active diarrhea 13 . Any medical , geographic , social factor make study participation impractical precluding followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>